Cas9 mRNA was in vitro transcribed from pXT7 using the mMessage mMachine kit (ThermoFisher) as previously described with some modifications [42 (link)]. CRISPR/Cas9 target site in exon 3 of nrg1 were identified using ZiFit software [43 (link)] and zebrafish genomic sequence, build GRCz9 [44 (link)]. Single stranded oligonucleotides corresponding to the targeting sequence were annealed and cloned into the DR274 vector (Addgene) [45 (link)], then transcribed in vitro with T7 MaxiScript kit (ThermoFisher). Cas9 plasmid was generously provided by Dr. Jing-Wei Xiong. Embryos were injected at the one cell stage with 1–2 nl of a mixture containing 1200 ng Cas9, 50–75 ng gRNA, 10 mM MgCl, and 0.01% phenol red. gRNA targeting efficiency was determined by High Resolution Melt Analysis (HRMA) [46 (link)] as described below using primers flanking the target site. F1 offspring from F0 founders that carry favorable mutations, determined by DNA sequencing of the target site, were raised to adulthood. Heterozygous F1 fish were interbred to produce homozygous wild type, homozygous mutant, and heterozygous mutant offspring.
Free full text: Click here